Responsible Procurement

Responsible Procurement

BeiGene understands the importance of working with suppliers who share our commitment to developing high quality products and responsible operations, including through mitigating our impact on the environment. As our company continues to grow, our procurement team has evolved into a global function, allowing all regions to work together in a coordinated fashion to ensure the safety and quality of the products we buy.

Climate Resiliency

In 2022, we completed our first holistic greenhouse gas (GHG) emissions inventory, including emissions from our own operations (Scopes 1 and 2 emissions) and our value chain (Scope 3 emissions). We have since set a carbon reduction goal across our Scope 1 and 2 emissions and are working to establish a Scope 3 carbon reduction goal by 2025. Read more about our how we are taking climate action within our value chain in our Responsible Business & Sustainability report.

Ethical Sourcing

We seek to work with suppliers who share our values and high business and ethical standards. BeiGene strongly encourages our partners adhere to responsible business practices outlined in our Supplier Code of Conduct, ensuring that the materials and ingredients we source are produced with fairness and respect for both people and the planet. We’ve initiated efforts to engage with key suppliers to raise awareness of material risk exposures, build capacity within our supplier base to track environmental data, and foster climate maturity in our value chain.

Supplier Diversity

BeiGene is committed to working with suppliers who represent the populations our medications support. Understanding that our work with small and diverse suppliers can contribute to stronger economic gains for underserved populations while also providing unique solutions, perspectives, and ideas to our business, we are committed to growing our relationships and pursuing innovations in patient health.

We assess the performance of our small and diverse supplier efforts annually. In tandem with our efforts to provide best-in-class care to our patients, BeiGene will continue to partner with suppliers of all backgrounds, helping them thrive so that we can make an impact, together.

BeiGene strongly encourages qualified small and diverse suppliers to become registered, either through government programs, third party organizations or self-certification. Resources for certification are available through the U.S. Small Business Administration. See below for diversity classifications:

Diverse Supplier Classifications

  • Small Business Enterprise: A business is determined as small based on its relative employment and revenue in accordance with the U.S. SBA’s size standard corresponding to an NAICS code.
  • Small Disadvantaged Business: A business that is at least 51% owned and controlled by one or more individuals who are both socially and economically disadvantaged and is considered small according to the SBA’s size standards. Firms that receive 8A certification automatically qualify as an SDB.
  • Women Owned Small Business: A business that is at least 51% owned by one or more U.S. citizen women and is considered small according to the SBA’s size standards.
  • Veteran Owned Small Business: A business that is at least 51% owned and controlled by U.S. citizen(s) who are Veterans of the U.S. Armed Forces and is considered small as defined by the size standard corresponding to any NAICS code listed in the business’s SAM profile.
  • Service-Disabled Veteran Owned Small Business: A business that is at least 51% owned and controlled by one or more disabled veterans.
  • Historically Underutilized Business Zones (HUBZone): A business that is located in a historically underutilized business zone that is at least 51% owned and controlled by U.S. citizens, a Community Development Corporation, an agricultural cooperative, an Alaska Native corporation, a Native Hawaiian organization, or an Indian tribe, with at least 35% of its employees residing in a HUBZone.
  • Minority Owned Business: A business that is at least 51% owned and controlled by one or more people who are Hispanic or Latino, Black or African American, Native Hawaiian or Other Pacific Islander, Asian, and American Indian or Alaska Native.

To learn more about our efforts surrounding Diversity, Equity, Inclusion & Belonging at BeiGene, please visit our Culture page. To learn more about our efforts related to diversity in clinical trials, please visit our Commitment to Patients page.